| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
brain enriched guanylate kinase associated | 0.821 | 0.115 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
CRYZL2P-SEC16B readthrough | 0.861 | 0.231 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
solute carrier family 14 member 2 | 0.606 | 0.692 | 1.1E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
long intergenic non-protein coding RNA 1876 | 0.861 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
CADM3 antisense RNA 1 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
atypical chemokine receptor 1 (Duffy blood group) | 0.608 | 0.731 | 2.1E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
AKT serine/threonine kinase 3 | 0.512 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2013 | 2019 | ||||||||
|
DLG associated protein 2 | 0.736 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
BDNF antisense RNA | 0.638 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2014 | 2019 | |||||||||
|
jade family PHD finger 2 | 0.890 | 0.192 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2014 | 2019 | ||||||||
|
FPGT-TNNI3K readthrough | 0.890 | 0.154 | 3.2E-48 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2014 | 2019 | ||||||||
|
WD repeat domain 25 | 2.1E-05 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2014 | 2019 | ||||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2014 | 2019 | ||||||||
|
DLG associated protein 1 | 0.691 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2014 | 2019 | ||||||||
|
TNNI3 interacting kinase | 0.691 | 0.346 | 3.1E-48 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2014 | 2019 | ||||||||
|
protein tyrosine phosphatase receptor type D | 0.584 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2014 | 2019 | ||||||||
|
transmembrane protein 245 | 0.839 | 0.192 | 3.6E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2014 | 2019 | ||||||||
|
transient receptor potential cation channel subfamily C member 6 | 0.514 | 0.692 | 3.0E-07 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2014 | 2019 | ||||||||
|
aryl hydrocarbon receptor nuclear translocator like | 0.510 | 0.885 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2014 | 2019 | ||||||||
|
component of oligomeric golgi complex 6 | 0.644 | 0.577 | 6.4E-16 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2014 | 2019 | ||||||||
|
bromodomain and WD repeat domain containing 1 | 0.839 | 0.192 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2014 | 2019 | ||||||||
|
adenosine deaminase RNA specific B2 (inactive) | 0.716 | 0.308 | 0.86 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2014 | 2019 | ||||||||
|
zinc finger protein 131 | 0.805 | 0.231 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2014 | 2019 | ||||||||
|
DET1 partner of COP1 E3 ubiquitin ligase | 0.68 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2014 | 2019 |